oligotherapy products limited
oligotherapy products limited Company Information
Company Number
02973020
Website
www.oligotherapy.co.ukRegistered Address
14 woodlands road, sonning common, reading, berkshire, RG4 9TE
Industry
Agents specialised in the sale of other particular products
Other human health activities
Telephone
01189721236
Next Accounts Due
June 2025
Group Structure
View All
Directors
Colleen O'Flaherty-Hilder30 Years
Shareholders
c.e. o'flaherty-hilder 100%
oligotherapy products limited Estimated Valuation
Pomanda estimates the enterprise value of OLIGOTHERAPY PRODUCTS LIMITED at £17.6k based on a Turnover of £36k and 0.49x industry multiple (adjusted for size and gross margin).
oligotherapy products limited Estimated Valuation
Pomanda estimates the enterprise value of OLIGOTHERAPY PRODUCTS LIMITED at £0 based on an EBITDA of £-3.4k and a 4.17x industry multiple (adjusted for size and gross margin).
oligotherapy products limited Estimated Valuation
Pomanda estimates the enterprise value of OLIGOTHERAPY PRODUCTS LIMITED at £14.1k based on Net Assets of £7.7k and 1.84x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Oligotherapy Products Limited Overview
Oligotherapy Products Limited is a live company located in reading, RG4 9TE with a Companies House number of 02973020. It operates in the agents specialized in the sale of other particular products sector, SIC Code 46180. Founded in October 1994, it's largest shareholder is c.e. o'flaherty-hilder with a 100% stake. Oligotherapy Products Limited is a mature, micro sized company, Pomanda has estimated its turnover at £36k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Oligotherapy Products Limited Health Check
Pomanda's financial health check has awarded Oligotherapy Products Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £36k, make it smaller than the average company (£6m)
- Oligotherapy Products Limited
£6m - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (6.6%)
- Oligotherapy Products Limited
6.6% - Industry AVG
Production
with a gross margin of 32.8%, this company has a comparable cost of product (32.8%)
- Oligotherapy Products Limited
32.8% - Industry AVG
Profitability
an operating margin of -11.9% make it less profitable than the average company (5.9%)
- Oligotherapy Products Limited
5.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (18)
- Oligotherapy Products Limited
18 - Industry AVG
Pay Structure
on an average salary of £40.9k, the company has an equivalent pay structure (£40.9k)
- Oligotherapy Products Limited
£40.9k - Industry AVG
Efficiency
resulting in sales per employee of £36k, this is less efficient (£210.7k)
- Oligotherapy Products Limited
£210.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Oligotherapy Products Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Oligotherapy Products Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 90 days, this is more than average (42 days)
- Oligotherapy Products Limited
42 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 16 weeks, this is less cash available to meet short term requirements (65 weeks)
16 weeks - Oligotherapy Products Limited
65 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 33.1%, this is a lower level of debt than the average (39.2%)
33.1% - Oligotherapy Products Limited
39.2% - Industry AVG
OLIGOTHERAPY PRODUCTS LIMITED financials
Oligotherapy Products Limited's latest turnover from September 2023 is estimated at £36 thousand and the company has net assets of £7.7 thousand. According to their latest financial statements, we estimate that Oligotherapy Products Limited has 1 employee and maintains cash reserves of £1.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 44,131 | 39,267 | 36,159 | 24,689 | 13,800 | ||||||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Cost Of Sales | 16,653 | 13,436 | 13,928 | 11,254 | 9,589 | ||||||||||
| Gross Profit | 27,478 | 25,831 | 22,231 | 13,435 | 4,211 | ||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Interest Receivable | 1 | 1 | 1 | 0 | 0 | ||||||||||
| Pre-Tax Profit | 9,317 | 6,806 | 6,941 | 618 | -5,522 | ||||||||||
| Tax | -1,961 | -270 | 0 | 0 | 0 | ||||||||||
| Profit After Tax | 7,356 | 6,536 | 6,941 | 618 | -5,522 | ||||||||||
| Dividends Paid | 6,000 | 6,000 | 6,000 | 0 | 0 | ||||||||||
| Retained Profit | 1,356 | 536 | 941 | 618 | -5,522 | ||||||||||
| Employee Costs | 896 | 1,340 | |||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 3,544 | 4,430 | 4,989 | 2,143 | 2,244 | 2,037 | 1,270 | 421 | 1,107 | 1,793 | 1,690 | 2,253 | 382 | 509 | 679 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 3,544 | 4,430 | 4,989 | 2,143 | 2,244 | 2,037 | 1,270 | 421 | 1,107 | 1,793 | 1,690 | 2,253 | 382 | 509 | 679 |
| Stock & work in progress | 6,000 | 6,000 | 5,500 | 3,500 | 4,800 | 9,000 | 8,277 | 8,277 | 0 | 0 | 0 | 0 | 0 | 0 | 1,200 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15,584 | 9,002 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,795 | 7,184 | 3,871 | 1,200 | 0 |
| Cash | 1,190 | 4,133 | 733 | 3,147 | 2,617 | 2,147 | 2,358 | 1,924 | 0 | 0 | 1,200 | 1,200 | 5,579 | 2,434 | 2,394 |
| misc current assets | 762 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 7,952 | 10,133 | 6,233 | 6,647 | 7,417 | 11,147 | 10,635 | 10,201 | 15,584 | 9,002 | 11,995 | 8,384 | 9,450 | 3,634 | 3,594 |
| total assets | 11,496 | 14,563 | 11,222 | 8,790 | 9,661 | 13,184 | 11,905 | 10,622 | 16,691 | 10,795 | 13,685 | 10,637 | 9,832 | 4,143 | 4,273 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 107 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,761 | 7,970 | 480 | 480 | 480 | 480 | 360 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,252 | 2,120 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 3,800 | 2,729 | 3,211 | 4,898 | 2,706 | 4,684 | 4,851 | 2,884 | 0 | 0 | 7,961 | 6,269 | 6,000 | 0 | 0 |
| total current liabilities | 3,800 | 2,729 | 3,211 | 4,898 | 2,706 | 4,684 | 4,958 | 2,884 | 7,761 | 7,970 | 8,441 | 6,749 | 6,480 | 1,732 | 2,480 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 660 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 660 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 3,800 | 2,729 | 3,211 | 4,898 | 2,706 | 4,684 | 4,958 | 2,884 | 7,761 | 8,630 | 8,441 | 6,749 | 6,480 | 1,732 | 2,480 |
| net assets | 7,696 | 11,834 | 8,011 | 3,892 | 6,955 | 8,500 | 6,947 | 7,738 | 8,930 | 2,165 | 5,244 | 3,888 | 3,352 | 2,411 | 1,793 |
| total shareholders funds | 7,696 | 11,834 | 8,011 | 3,892 | 6,955 | 8,500 | 6,947 | 7,738 | 8,930 | 2,165 | 5,244 | 3,888 | 3,352 | 2,411 | 1,793 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 886 | 1,108 | 1,249 | 536 | 562 | 509 | 318 | 563 | 751 | 127 | 170 | 226 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | -1,961 | -270 | 0 | 0 | 0 | ||||||||||
| Stock | 0 | 500 | 2,000 | -1,300 | -4,200 | 723 | 0 | 8,277 | 0 | 0 | 0 | 0 | 0 | -1,200 | 1,200 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,584 | 6,582 | -1,793 | 3,611 | 3,313 | 2,671 | 1,200 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7,761 | -209 | 7,490 | 0 | 0 | 0 | 120 | 360 |
| Accruals and Deferred Income | 1,071 | -482 | -1,687 | 2,192 | -1,978 | -167 | 1,967 | 2,884 | 0 | -7,961 | 1,692 | 269 | 6,000 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,252 | -868 | 2,120 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -660 | 660 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 1 | 1 | 1 | 0 | 0 | ||||||||||
| cash flow from financing | 1 | 1 | -1,251 | -868 | 9,435 | ||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -2,943 | 3,400 | -2,414 | 530 | 470 | -211 | 434 | 1,924 | 0 | -1,200 | 0 | -4,379 | 3,145 | 40 | 2,394 |
| overdraft | 0 | 0 | 0 | 0 | 0 | -107 | 107 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -2,943 | 3,400 | -2,414 | 530 | 470 | -104 | 327 | 1,924 | 0 | -1,200 | 0 | -4,379 | 3,145 | 40 | 2,394 |
oligotherapy products limited Credit Report and Business Information
Oligotherapy Products Limited Competitor Analysis
Perform a competitor analysis for oligotherapy products limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in RG4 area or any other competitors across 12 key performance metrics.
oligotherapy products limited Ownership
OLIGOTHERAPY PRODUCTS LIMITED group structure
Oligotherapy Products Limited has no subsidiary companies.
Ultimate parent company
OLIGOTHERAPY PRODUCTS LIMITED
02973020
oligotherapy products limited directors
Oligotherapy Products Limited currently has 1 director, Mrs Colleen O'Flaherty-Hilder serving since Oct 1994.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Colleen O'Flaherty-Hilder | United Kingdom | 72 years | Oct 1994 | - | Director |
P&L
September 2023turnover
36k
-15%
operating profit
-4.3k
0%
gross margin
32.8%
+0.86%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
7.7k
-0.35%
total assets
11.5k
-0.21%
cash
1.2k
-0.71%
net assets
Total assets minus all liabilities
Similar Companies
oligotherapy products limited company details
company number
02973020
Type
Private limited with Share Capital
industry
46180 - Agents specialised in the sale of other particular products
86900 - Other human health activities
incorporation date
October 1994
age
30
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
14 woodlands road, sonning common, reading, berkshire, RG4 9TE
Bank
-
Legal Advisor
-
oligotherapy products limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to oligotherapy products limited.
oligotherapy products limited Companies House Filings - See Documents
| date | description | view/download |
|---|
